News
Anergis Reports Encouraging Seasonal Clinical Results with AllerT, a Novel
Product for Ultra Fast Desensitization of Patients Allergic to Birch Pollen.
Press release, July 17, 2009 (PDF)
11 May 2009
Anergis SA Announces the Appointments of Jean-Michel Dayer, M.D., Raif S.
Geha, M.D. and Stefan Kaufmann Ph.D. to the Company's International
Scientific Advisory Board
Press release, May 11, 2009 (PDF)
22 April 2009.
Anergis announces successful results of a phase I/IIA clinical trial with subcutaneous AllerT, its novel product for desensitization of patients allergic to birch pollen.
Press release, April 22, 2009 (PDF)
15 April 2009.
Anergis in the press – L’Hebdo 15 April 2009 (French)
1 January 2009
Vincent Charlon joins Anergis as Chief Executive Officer (CEO); Christophe Reymond becomes Chief Scientific Officer (CSO).
18 June 2008
Press release, June 18, 2008 (PDF)
3 April 2007
Le Temps du 3 avril 2007 (HTML)
27 May 2007
Agefi du 27 mai 2005 (PDF)